Sundar PichaiSundar Pichai earned $164M in 2023

Dawn M. H. H. McGowan is the CEO of Exact Sciences Corp, a company that is at the forefront of cancer diagnostics. She has been leading the charge since January 2023. Under her leadership, Exact Sciences aims to change how...

Quick Links
E

Dawn M. H. H. McGowan

CEO of Exact Sciences

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of Exact Sciences for

2 years 5 months (Jan 2023 - Present)

Previous Experience

Chief Operating Officer at Exact Sciences Corporation, various leadership roles at Exact Sciences Corporation

Rivals

Competitors/colleagues of Dawn M. H. H. McGowan

Holdings

See how much did Dawn M. H. H. McGowan make over time.

As the CEO of Exact Sciences, a major player in cancer diagnostics, Dawn M. H. H. McGowan essentially holds a significant stake in transforming cancer care. There are no specific holdings data listed for her, emphasizing perhaps a focus on...

Loading...

Insider Trading

See recent insider trades of Dawn M. H. H. McGowan.

No insider trades found for this CEO.

Compensation History

See how much did Dawn M. H. H. McGowan make over time.

In 2023, Dawn M. H. H. McGowan earned a total compensation package of $2,500,080 at Exact Sciences. This includes a base salary of $1,041,700, plus a rewarding bonus of $1,458,380, which was driven by the company meeting and exceeding corporate goals this past year. Notably, the bonus payouts reached 133% of the target thanks to strong financial performance. While she does not hold vested stocks, the compensation structure encourages a focus on long-term outcomes with performance stock units. This aligns her interests with those of shareholders and reflects a commitment to the company's future growth.

Year

2023

Total Compensation

$2.50M

Salary

$1.04M

Board Justification

The compensation philosophy emphasizes a pay-for-performance culture, aligning executive compensation with the company's long-term performance and shareholder interests.

Bonus

$1.46M

Board Justification

The annual cash bonus opportunity for 2023 was based on the achievement of corporate goals, with a payout of 133% of target due to strong performance in revenue and adjusted EBITDA.

Other

$0.00

Board Justification

No additional compensation was reported outside of salary, bonus, and stock options.

Restricted Stock

$0.00(0 RSU)

Board Justification

No specific vested stock was reported for 2023; however, the compensation structure includes performance stock units (PSUs) and restricted stock units (RSUs) that are tied to performance metrics.

Performance Metrics

The performance metrics for 2023 included total revenue, adjusted EBITDA, and specific milestones related to product development and customer satisfaction.

Other Exact Sciences CEOs

Here are other CEOs of Exact Sciences